Azacitidine
- Product NDC
- 0781-3253
- 11-digit product format
- 007813253
- Labeler code
- 0781
- Product ID
- 0781-3253_84226739-5b8c-4e28-a17e-793af710a06f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- azacitidine
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Sandoz Inc
- Application
- NDA050794
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2013-09-16
- Marketing end
- 2025-02-28
- Substance
- AZACITIDINE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0781-3253-94 | 00781325394 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0781-3253-94) | 2013-09-16 | 0000-00-00 | No | No | Current |